Correlation Between DiaMedica Therapeutics and Oncolytics Biotech
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Oncolytics Biotech, you can compare the effects of market volatilities on DiaMedica Therapeutics and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Oncolytics Biotech.
Diversification Opportunities for DiaMedica Therapeutics and Oncolytics Biotech
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between DiaMedica and Oncolytics is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Oncolytics Biotech go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Oncolytics Biotech
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.93 times more return on investment than Oncolytics Biotech. However, DiaMedica Therapeutics is 1.07 times less risky than Oncolytics Biotech. It trades about 0.1 of its potential returns per unit of risk. Oncolytics Biotech is currently generating about -0.3 per unit of risk. If you would invest 551.00 in DiaMedica Therapeutics on November 2, 2024 and sell it today you would earn a total of 34.00 from holding DiaMedica Therapeutics or generate 6.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Oncolytics Biotech
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Oncolytics Biotech |
DiaMedica Therapeutics and Oncolytics Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Oncolytics Biotech
The main advantage of trading using opposite DiaMedica Therapeutics and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Oncolytics Biotech vs. Scpharmaceuticals | Oncolytics Biotech vs. Milestone Pharmaceuticals | Oncolytics Biotech vs. Seres Therapeutics | Oncolytics Biotech vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |